Heterogeneity of circulating tumor cells in primary breast cancer patients

被引:0
|
作者
Bystricky, Branislav
Karaba, Marian
Benca, Juraj
Vavrova, Ludmila
Markus, Jan
Konecny, Michal
Pindak, Daniel
Sufliarsky, Jozef
Mardiak, Jozef
Mego, Michal
机构
[1] Univ Hosp Trencin, Trencin, Slovakia
[2] Natl Canc Inst, Bratislava, Slovakia
[3] St Elisabeth Oncol Inst, Dept Genet, Bratislava, Slovakia
[4] Comenius Univ, Fac Med, Natl Canc Inst, Dept Oncol 2, Bratislava, Slovakia
[5] Comenius Univ, Fac Med, Oncol Clin 2, Bratislava, Slovakia
[6] Natl Canc Inst, Dept Clin Oncol, Bratislava, Slovakia
[7] Comenius Univ, Fac Med, Dept Oncol 2, Bratislava, Slovakia
[8] Natl Canc Inst, Bratislava, Slovakia
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e22037
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Circulating tumor cells (CTCs) in peripheral blood of primary breast cancer patients.
    Rack, B. K.
    Schindlbeck, C.
    Janni, W. J.
    Hofmann, S.
    Jeschke, U.
    Thurner-Hermanns, E.
    Hilfrich, J.
    Beckmann, M. W.
    Pantel, K.
    Lichtenegger, W.
    Sommer, H.
    Friese, K.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S215 - S215
  • [22] Circulating tumor cells and Epithelial Mesenchymal Transition in primary breast cancer patients.
    Mego, M.
    Karaba, M.
    Minarik, G.
    Benca, J.
    Sedlackova, T.
    Manasova, D.
    Sieberova, G.
    Gronesova, P.
    Pechan, J.
    Mardiak, J.
    Reuben, J. M.
    CANCER RESEARCH, 2012, 72
  • [23] Detection of circulating tumor cells in peripheral blood of patients with primary and metastatic breast cancer
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 138 - 138
  • [24] Prognostic Relevance of Circulating Tumor Cells in the Peripheral Blood of Primary Breast Cancer Patients
    Rack, B.
    Schindlbeck, C.
    Andergassen, U.
    Lorenz, R.
    Zwingers, T.
    Schneeweiss, A.
    Lichtenegger, W.
    Beckmann, M. W.
    Sommer, H.
    Pantel, K.
    Friese, K.
    Janni, W.
    CANCER RESEARCH, 2010, 70
  • [25] Circulating tumor cells in adjuvant breast cancer patients
    Almokadem, S
    Leitel, K
    Harvey, HA
    Bannon, E
    Ali, SM
    Miller, MC
    Repollet, M
    Terstapenn, LWWM
    Doyle, GV
    Frazier, T
    Lipton, A
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S84 - S85
  • [26] Characterization of Circulating Tumor Cells in Breast Cancer Patients
    Lu, GuoFen
    Wu, Hui
    Ma, DeKui
    CLINICAL LABORATORY, 2023, 69 (07) : 1371 - 1380
  • [27] Circulating tumor cells in patients with breast cancer dormancy
    Meng, SD
    Tripathy, D
    Frenkel, EP
    Shete, S
    Naftalis, EZ
    Huth, JF
    Beitsch, PD
    Leitch, M
    Hoover, S
    Euhus, D
    Haley, B
    Morrison, L
    Fleming, TP
    Herlyn, D
    Terstappen, LWMM
    Fehm, T
    Tucker, TF
    Lane, N
    Wang, JQ
    Uhr, JW
    CLINICAL CANCER RESEARCH, 2004, 10 (24) : 8152 - 8162
  • [28] Circulating tumor cells and breast cancer-specific mutations in primary breast cancer
    Mego, Michal
    Karaba, Marian
    Sedlackova, Tatiana
    Benca, Juraj
    Repiska, Gabriela
    Krasnicanova, Lucia
    Macuch, Jan
    Sieberova, Gabriela
    Jurisova, Silvia
    Pindak, Daniel
    Kalavska, Katarina
    Mardiak, Jozef
    Minarik, Gabriel
    MOLECULAR AND CLINICAL ONCOLOGY, 2020, 12 (06) : 565 - 573
  • [29] The effect of primary tumor heterogeneity on circulating tumor DNA detection in colorectal cancer patients
    Yaegashi, Mizunori
    Iwaya, Takeshi
    Sato, Kei
    Endo, Fumitaka
    Fujita, Masashi
    Nakagawa, Hidewaki
    Nishizuka, Satoshi
    CANCER SCIENCE, 2018, 109 : 546 - 546
  • [30] Surviving gene expression in the primary tumor and circulating tumor cells in breast cancer
    Shlyakhtunou, Y.
    EUROPEAN JOURNAL OF CANCER, 2016, 57 : S127 - S127